Shandong Boan Biotechnology 과거 수익 실적
과거 기준 확인 2/6
Shandong Boan Biotechnology has been growing earnings at an average annual rate of 31.7%, while the Biotechs industry saw earnings growing at 31.7% annually. Revenues have been growing at an average rate of 29.4% per year. Shandong Boan Biotechnology's return on equity is 4.4%, and it has net margins of 8.6%.
주요 정보
31.7%
수익 성장률
127.1%
EPS 성장률
| Biotechs 산업 성장 | 11.0% |
| 매출 성장률 | 29.4% |
| 자기자본 수익률 | 4.4% |
| 순이익 | 8.6% |
| 최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
수익 및 비용 분석
Shandong Boan Biotechnology 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Jun 24 | 720 | 62 | 323 | 190 |
| 31 Mar 24 | 669 | -29 | 316 | 211 |
| 31 Dec 23 | 618 | -119 | 308 | 231 |
| 30 Sep 23 | 587 | -209 | 305 | 294 |
| 30 Jun 23 | 557 | -298 | 302 | 357 |
| 31 Mar 23 | 536 | -315 | 299 | 379 |
| 31 Dec 22 | 516 | -332 | 296 | 400 |
| 30 Sep 22 | 442 | -291 | 253 | 345 |
| 30 Jun 22 | 367 | -251 | 211 | 289 |
| 31 Mar 22 | 263 | -238 | 153 | 260 |
| 31 Dec 21 | 159 | -225 | 96 | 232 |
양질의 수익: 6955 has a high level of non-cash earnings.
이익 마진 증가: 6955 became profitable in the past.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: 6955 has become profitable over the past 5 years, growing earnings by 31.7% per year.
성장 가속화: 6955 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
수익 대 산업: 6955 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (5.5%).
자기자본 수익률
높은 ROE: 6955's Return on Equity (4.4%) is considered low.